The 37 references in paper A. Kholin A., I. Fedonyuk D., L. Kolpakchi M, E. Il`ina S., K. Mukhin Yu., А. Холин А., И. Федонюк Д., Л. Колпакчи М., Е. Ильина С., К. Мухин Ю. (2015) “Аггравация эпилепсии при терапии леветирацетамом: наблюдение 28 клинических случаев, факторы риска и профилактика // AGGRAVATION OF EPILEPSY ON LEVETIRACETAM THERAPY: 28 CLINICAL OBSERVATIONS, RISK FACTORS AND POSSIBILITY OF PROPHYLACTIC” / spz:neicon:rjdn:y:2014:i:1:p:5-22

1
Белоусова Е.Д. Кеппра в рациональной политерапии эпилепсии у детей. Рус мед журн 2008;16(4):192–4.
(check this in PDF content)
2
Воронкова К.В., Петрухин А.С., Пылаева О.А., Холин А.С. Рациональная антиэпилептическая фармакология. Руководство для врачей. М.: Бином, 2008. 192 с.
(check this in PDF content)
3
Мухин К.Ю. Идиопатическая фокальная эпилепсия с псевдогенерализованными приступами – особая форма эпилепсии в детском возрасте. Рус журн дет неврол 2009;4(2):3–19.
(check this in PDF content)
4
Мухин К.Ю. Доброкачественные эпилептиформные нарушения детского возраста и их специфичность. В кн.: Мухин К.Ю., Петрухин А.С., Глухова Л.Ю. Эпилепсия: атлас электро-клинической диагностики. М.: Альварес Паблишинг, 2004. С. 277–88.
(check this in PDF content)
5
Мухин К.Ю., Головтеев А.Л. Приобретенный эпилептический лобный синдром. Рус журн дет неврол 2008;3(1):21–9.
(check this in PDF content)
6
Мухин К.Ю., Пилия С.В., Чадаев В.А. и др. Кеппра в лечении эпилепсии: эффективность и переносимость. Журн неврол психиатр им. С.С. Корсакова 2005;105(1):49–51.
(check this in PDF content)
7
Atefy R., Tettenborn B. Nonconvulsive status epilepticus on treatment with levetiracetam. Epilepsy Behav 2005;6(4):613–6.
(check this in PDF content)
8
Ben-Menachem E., Falter U. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group. Epilepsia 2000;41(10):1276–83.
(check this in PDF content)
9
Betts T., Waegemans T., Crawford P. A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy. Seizure 2000;9(2):80–7.
(check this in PDF content)
10
Caraballo R.H., Cersósimo R., De los Santos C. Levetiracetam-induced seizure aggravation associated with continuous spikes and waves during slow sleep in children with refractory epilepsies. Epileptic Disord 2010;12(2):146–50.
(check this in PDF content)
11
Cereghino J.J., Biton V., Abou-Khalil B. et al. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 2000;55(2):236–42.
(check this in PDF content)
12
Los Reyes E.C., Sharp G.B., Williams J.P., Hale S.E. Levetiracetam in the treatment of Lennox-Gastaut syndrome. Pediatr Neurol 2004;30(4):254–6.
(check this in PDF content)
13
Eue S., Grumbt M., Müller M., Schulze A. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam. Epilepsy Behav 2009;15(4):467–9.
(check this in PDF content)
14
French J.A., Tonner F. Levetiracetam. In: Shorvon S., Perucca E., Engel J.Jr. et al. The treatment of epilepsy. 3rd ed. Oxford: Willey-Blackwell, 2009:559–73.
(check this in PDF content)
15
Giroux P.C., Salas-Prato M., Théorêt Y., Carmant L. Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy. Seizure 2009;18(8):559–63.
(check this in PDF content)
16
Glauser T.A., Ayala R., Elterman R.D. et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 2006;66(11):1654–60.
(check this in PDF content)
17
Gomer B., Wagner K., Frings L. et al. The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate. Epilepsy Behav 2007;10(3):486–94.
(check this in PDF content)
18
Goraya J.S., Khurana D.S., Valencia I. et al. Intravenous levetiracetam in children with epilepsy. Pediatr Neurol 2008;38(3):177–80.
(check this in PDF content)
19
Grosso S., Franzoni E., Coppola G. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Seizure 2005;14(4):248–53.
(check this in PDF content)
20
Haberlandt E., Sigl S.B., Scholl-Buergi S. et al. Levetiractam in the treatment of two children with myoclonic status epilepticus. Eur J Paediatr Neurol 2009;13(6):546–9.
(check this in PDF content)
21
Kirmani B.F., Crisp E.D., Kayani S., Rajab H. Role of intravenous levetiracetam in acute seizure management of children. Pediatr Neurol 2009;41(1):37–9.
(check this in PDF content)
22
Kossoff E.H., Los J.G., Boatman D.F. A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy. Epilepsy Behav 2007;11(4):514–7.
(check this in PDF content)
23
Labate A., Colosimo E., Gambardella A. et al. Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study. Seizure 2006;15(3):214–8.
(check this in PDF content)
24
Lawlor K.M., Devlin A.M. Levetiracetam in the treatment of infantile spasms. Eur J Paediatr Neurol 2005;9(1):19–22.
(check this in PDF content)
25
Magaudda A., Gelisse P., Genton P. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations. Epilepsia 2004;45(6):678–81.
(check this in PDF content)
26
Mandelbaum D.E., Bunch M., Kugler S.L. et al. Efficacy of levetiracetam at 12 months in children classified by seizure type, cognitive status, and previous anticonvulsant drug use. J Child Neurol 2005;20(7):590–4.
(check this in PDF content)
27
Mikati M.A., El Banna D., Sinno D., Mroueh S. Response of infantile spasms to levetiracetam. Neurology 2008;70(7):574–5.
(check this in PDF content)
28
Opp J., Tuxhorn I., May T. et al. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany Seizure 2005;14(7):476–84.
(check this in PDF content)
29
Otoul С., De Smedt H., Stockis A. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. Epilepsia 2007;48(11):2111–5.
(check this in PDF content)
30
Panayiotopoulos С.P. The Epilepsies. Seizures, Syndromes and Management. Oxfordshire (UK): Bladon Medical Publishing, 2005.
(check this in PDF content)
31
Papacostas S., Kkolou E., Papathanasiou E. Levetiracetam in three cases of progressive myoclonus epilepsy. Pharm World Sci 2007;29(3):164–6.
(check this in PDF content)
32
Peake D., Mordekar S., Gosalakkal J. et al. Retention rate of levetiracetam in children with intractable epilepsy at 1 year. Seizure 2007:16(2):185–9.
(check this in PDF content)
33
Reiter P.D., Huff A.D., Knupp K.G., Valuck R.J. Intravenous levetiracetam in the management of acute seizures in children. Pediatr Neurol 2010;43(2):117–21.
(check this in PDF content)
34
Somerville E.R. Aggravation of partial seizures by antiepileptic drugs: is there evidence from clinical trials? Neurology 2002;59(1):79–83.
(check this in PDF content)
35
Verrotti A., Coppola G., Manco R. et al. Levetiracetam monotherapy for children and Child NEUROLOGY_01_2014 Block.indd 21Child NEUROLOGY_01_2014 Block.indd 2104.03.2014 14:18:0304.03.2014 14:18:03 adolescents with benign rolandic seizures Seizure 2007;16(3):271–5.
(check this in PDF content)
36
Stülpnagel C., Kluger G., Leiz S., Holthausen H. Levetiracetam as add-on therapy in different subgroups of "benign" idiopathic focal epilepsies in childhood. Epilepsy Behav 2010; 17(2):193–8.
(check this in PDF content)
37
Wang S.B., Weng W.C., Fan P.C., Lee W.T. Levetiracetam in continuous spike waves during slow-wave sleep syndrome. Pediatr Neurol 2008;39(2):85–90. Child NEUROLOGY_01_2014 Block.indd 22Child NEUROLOGY_01_2014 Block.indd 2204.03.2014 14:18:0304.03.2014 14:18:03
(check this in PDF content)